Position in VTRS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$4,137,193
-$573,499 QoQ
Shares Held
306,232
-19.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $123,026,116 across 22 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
106,440 | $63,116,789 | |
| 2 | ZTS |
Zoetis Inc.
|
136,420 | $16,126,206 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
96,485 | $12,710,933 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
278,288 | $6,659,431 | |
| 5 | VTRS |
Viatris Inc
This page
|
306,232 | $4,137,193 | |
| 6 | ALKS |
Alkermes plc.
|
110,212 | $3,897,096 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
83,338 | $2,540,142 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
35,634 | $2,112,027 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,137,193 | 306,232 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,710,692 | 378,369 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,511,143 | 354,661 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $6,267,510 | 701,849 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $3,131,497 | 359,529 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $2,052,581 | 164,866 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,228,538 | 191,950 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $938,851 | 88,321 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,085,058 | 90,876 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,000,962 | 92,425 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $892,408 | 90,508 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,080,335 | 1,310,655 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,456,899 | 1,294,896 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $578,036 | 51,935 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $440,654 | 51,720 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $538,650 | 51,447 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $556,501 | 51,149 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $882,345 | 65,214 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $904,611 | 66,761 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $954,572 | 66,800 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $11,273,328 | 806,967 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $981,694 | 52,385 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||